| Literature DB >> 28364819 |
Juan F Gallegos-Orozco1, Michael R Charlton2.
Abstract
Indications for liver transplant have been extended, and older and sicker patients are undergoing transplantation. Infectious, malignant, and cardiovascular diseases account for the most posttransplant deaths. Cirrhotic patients can develop heart disease through systemic diseases affecting the heart and the liver, cirrhosis-specific heart disease, or common cardiovascular. No single factor can predict posttransplant cardiovascular complications. Patients with history of cardiovascular disease, and specific abnormalities on echocardiography, electrocardiography, or serum markers of heart disease seem to be at increased risk of complications. Pretransplant cardiovascular evaluation is essential to detecting these risk factors so their effects can be mitigated through appropriate intervention.Entities:
Keywords: Atrial fibrillation; Cardiovascular disease; Cirrhotic cardiomyopathy; Heart failure; Ischemic stroke; Liver transplant; Myocardial infarction
Mesh:
Year: 2017 PMID: 28364819 DOI: 10.1016/j.cld.2016.12.009
Source DB: PubMed Journal: Clin Liver Dis ISSN: 1089-3261 Impact factor: 6.126